Roger Pomerantz | CollPlant, Chairman of the Board of Directors
Tissue repair company Collplant has appointed Roger Pomerantz to the role of chairman of the board of directors
Nasdaq-listed tissue repair company Collplant Holdings Ltd. has appointed Roger Pomerantz to the role of chairman of the board of directors. Currently, Pomerantz serves as the president, CEO, and chairman of biotech company ContraFect Corporation. Prior to that, Pomerantz held similar positions at various companies, including microbiome therapeutics company Seres Therapeutics, Inc.
Founded in 2004, Rehovot, Israel-based Collplant develops and manufactures collagen-based regenerative medical treatments and biological ink for the 3D printing of tissues and organs.